Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions

[1]  C. Bartram,et al.  Perilunate and Lunate Dislocations , 2023, Advanced emergency nursing journal.

[2]  Mpox (monkeypox): Diagnosis, prevention, and management in adults. , 2023, The Nurse Practitioner.

[3]  Stanley J Tamaki,et al.  Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes , 2023, Cell.

[4]  Haiquan Chen,et al.  Excellent survival of pathological N0 small cell lung cancer patients following surgery , 2023, European Journal of Medical Research.

[5]  Yang Zhang,et al.  Selective mediastinal lymph node dissection strategy for clinical T1N0 invasive lung cancer: A prospective, multicenter, clinical trial. , 2023, Journal of Thoracic Oncology.

[6]  Jihoon Kim,et al.  Locoregional Lymphatic Delivery Systems Using Nanoparticles and Hydrogels for Anticancer Immunotherapy , 2022, Pharmaceutics.

[7]  V. Rusch,et al.  The IASLC Lung Cancer Staging Project: Overview of Challenges and Opportunities in Revising the Nodal Classification of Lung Cancer. , 2022, Journal of Thoracic Oncology.

[8]  S. Jalkanen,et al.  Lymph node lymphatic endothelial cells as multifaceted gatekeepers in the immune system. , 2022, Trends in immunology.

[9]  W. Hung,et al.  Reprogramming of sentinel lymph node microenvironment during tumor metastasis , 2022, Journal of Biomedical Science.

[10]  J. Meyerhardt,et al.  Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

[11]  Z. Chang,et al.  Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer , 2022, Journal of Experimental & Clinical Cancer Research.

[12]  Saurabh Shah,et al.  Nanotechnology based drug delivery systems: Does shape really matter? , 2022, International journal of pharmaceutics.

[13]  Daxing Zhu,et al.  LobE-Specific lymph node diSsectiON for clinical early-stage non-small cell lung cancer: protocol for a randomised controlled trial (the LESSON trial) , 2022, BMJ Open.

[14]  R. Abdi,et al.  Lymph node fibroblastic reticular cells preserve a tolerogenic niche in allograft transplantation through laminin α4 , 2022, The Journal of clinical investigation.

[15]  Xiawei Wei,et al.  Nanomaterial-Based Drug Delivery System Targeting Lymph Nodes , 2022, Pharmaceutics.

[16]  H. Augustin,et al.  Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression , 2022, The Journal of clinical investigation.

[17]  P. Kesharwani,et al.  Lymphatic targeting for therapeutic application using nanoparticulate systems , 2022, Journal of drug targeting.

[18]  J. Ahn,et al.  Nomenclature and Lymphatic Drainage Patterns of Abdominal Lymph Nodes , 2022, Journal of the Korean Society of Radiology.

[19]  Y. Akagi,et al.  Management of inguinal lymph node metastases from rectal and anal canal adenocarcinoma , 2022, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[20]  Nathan E. Reticker-Flynn,et al.  Lymph node colonization induces tumor-immune tolerance to promote distant metastasis , 2022, Cell.

[21]  M. Kubo,et al.  Lymph Nodes as Anti-Tumor Immunotherapeutic Tools: Intranodal-Tumor-Specific Antigen-Pulsed Dendritic Cell Vaccine Immunotherapy , 2022, Cancers.

[22]  Wei Wang,et al.  FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis , 2022, Cell Death & Disease.

[23]  Tianxin Lin,et al.  HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5‐WDR5‐dependent transcriptional program , 2022, Cancer communications.

[24]  Gerard Doherty,et al.  Surgical Management of Gastric Cancer: A Review. , 2022, JAMA surgery.

[25]  M. Lubner,et al.  What’s in a node? The clinical and radiologic significance of Virchow’s node , 2022, Abdominal Radiology.

[26]  Shenmin Zhang,et al.  Quantitative hypoxia mapping using a self-calibrated activatable nanoprobe , 2022, Journal of Nanobiotechnology.

[27]  T. Oskarsson,et al.  Tumor-Derived Lactic Acid Modulates Activation and Metabolic Status of Draining Lymph Node Stroma , 2022, Cancer immunology research.

[28]  S. Quezada,et al.  Tumor-educated Tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche. , 2022, Cell reports.

[29]  J. Merks,et al.  In transit metastases in children, adolescents and young adults with localized rhabdomyosarcoma of the distal extremities: Analysis of the EpSSG RMS 2005 study. , 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[30]  J. Shah,et al.  NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

[31]  G. Mariani,et al.  Sentinel Lymph Node Methods in Breast Cancer. , 2022, Seminars in nuclear medicine.

[32]  V. Prod’homme,et al.  Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular Cells. , 2022, Cancer research.

[33]  Quan P. Ly,et al.  Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

[34]  A. Sanabria,et al.  Prophylactic Central Neck Lymph Node Dissection in Low-risk Thyroid Carcinoma Patients Does Not Decrease the Incidence of Locoregional Recurrence , 2022, Annals of surgery.

[35]  S. Jinnai,et al.  Incidence and patterns of lymphatic drainage to the epitrochlear and popliteal sentinel lymph nodes in malignant melanoma of the distal extremities: a single‐institution retrospective study , 2022, International journal of dermatology.

[36]  Kongming Wu,et al.  Combination strategies with PD-1/PD-L1 blockade: current advances and future directions , 2022, Molecular cancer.

[37]  H. Ran,et al.  A novel targeted multifunctional nanoplatform for visual chemo-hyperthermia synergy therapy on metastatic lymph nodes via lymphatic delivery , 2021, Journal of Nanobiotechnology.

[38]  Jinghua Sun,et al.  A Natural Cuttlefish Melanin Nanoprobe for Preoperative and Intraoperative Mapping of Lymph Nodes. , 2021, Nanomedicine : nanotechnology, biology, and medicine.

[39]  Xiansong Wang,et al.  Lanthanide-based metal–organic frameworks solidified by gelatin-methacryloyl hydrogels for improving the accuracy of localization and excision of small pulmonary nodules , 2021, Journal of Nanobiotechnology.

[40]  K. Pantel,et al.  Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels , 2021, Clinical & experimental metastasis.

[41]  N. Hanna,et al.  Advances in systemic therapy for non-small cell lung cancer , 2021, BMJ.

[42]  N. Horvat,et al.  MRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response. , 2021, Clinical colorectal cancer.

[43]  H. Sekhon,et al.  The Lymphatic Spread of Lung Cancer: An Investigation of the Anatomy of the Lymphatic Drainage of the Lungs and Preoperative Mediastinal Staging. , 2021, Thoracic surgery clinics.

[44]  R. Reis,et al.  Precision biomaterials in cancer theranostics and modelling. , 2021, Biomaterials.

[45]  S. Thomas,et al.  Innovations in lymph node targeting nanocarriers. , 2021, Seminars in immunology.

[46]  J. Becker,et al.  Waiving Subsequent Complete Lymph Node Dissection in Melanoma Patients with Positive Sentinel Lymph Node Does Not Result in Worse Outcome on 20-Year Analysis , 2021, Cancers.

[47]  S. Leong,et al.  The lymphatic system and sentinel lymph nodes: conduit for cancer metastasis , 2021, Clinical & experimental metastasis.

[48]  A. Klassen,et al.  Comparison of upper extremity lymphedema after sentinel lymph node biopsy and axillary lymph node dissection: patient-reported outcomes in 3044 patients , 2021, Breast Cancer Research and Treatment.

[49]  B. Tallon,et al.  Melanoma sentinel lymph node biopsy and completion lymph node dissection: A regional hospital experience. , 2021, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[50]  P. Kesharwani,et al.  RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[51]  E. Morioka,et al.  The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancer , 2021, Breast Cancer.

[52]  A. Regev,et al.  Conventional type I dendric cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes. , 2021, Immunity.

[53]  H. Woo,et al.  Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects , 2021, Liver international : official journal of the International Association for the Study of the Liver.

[54]  C. Halin,et al.  The lymphatic vasculature: An active and dynamic player in cancer progression , 2021, Medicinal research reviews.

[55]  A. W. Lund,et al.  Tumor-draining lymph nodes: At the crossroads of metastasis and immunity , 2021, Science Immunology.

[56]  T. Curiel,et al.  Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma. , 2021, Immunity.

[57]  Xinjun Wang,et al.  Immune Characters and Plasticity of the Sentinel Lymph Node in Colorectal Cancer Patients , 2021, Journal of immunology research.

[58]  Jian Ye,et al.  Ratiometric Raman nanotags enable intraoperative detection of metastatic sentinel lymph node. , 2021, Biomaterials.

[59]  Su-jin Kim,et al.  A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma. , 2021, Surgery.

[60]  B. Ludewig,et al.  Communication, construction, and fluid control: lymphoid organ fibroblastic reticular cell and conduit networks. , 2021, Trends in immunology.

[61]  Yuanyuan Su,et al.  Rapid and Accurate Detection of Lymph Node Metastases Enabled through Fluorescent Silicon Nanoparticles-Based Exosome Probes. , 2021, Analytical chemistry.

[62]  R. Abdi,et al.  Lymph node fibroblastic reticular cells steer immune responses , 2021, Trends in immunology.

[63]  A. Noël,et al.  The pre-metastatic niche in lymph nodes: formation and characteristics , 2021, Cellular and Molecular Life Sciences.

[64]  M. Okada,et al.  Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer , 2021, Annals of Surgical Oncology.

[65]  R. Dahlstrom,et al.  Challenges and opportunities , 2021, Foundations of a Sustainable Economy.

[66]  N. Avril,et al.  PET/CT Variants and Pitfalls in Breast Cancers. , 2021, Seminars in nuclear medicine.

[67]  Huafeng Zhang,et al.  Metabolic reprogramming and epigenetic modifications on the path to cancer , 2021, Protein & Cell.

[68]  R. Zweemer,et al.  The feasibility of folate receptor alpha- and HER2-targeted intraoperative fluorescence-guided cytoreductive surgery in women with epithelial ovarian cancer: A systematic review. , 2021, Gynecologic oncology.

[69]  Dennis Jones,et al.  The multifaceted effects of breast cancer on tumor draining lymph nodes. , 2021, The American journal of pathology.

[70]  S. Irshad,et al.  Lymph Node Immune Profiles as Predictive Biomarkers for Immune Checkpoint Inhibitor Response , 2021, Frontiers in Molecular Biosciences.

[71]  N. Tanner,et al.  How I Do It: Mediastinal Staging for Lung Cancer. , 2021, Chest.

[72]  S. H. van der Burg,et al.  Therapeutic cancer vaccines , 2021, Nature Reviews Cancer.

[73]  T. Yoshikawa,et al.  Lymph node dissection for gastric cancer: Establishment of D2 and the current position of splenectomy in Europe and Japan. , 2021, European Journal of Surgical Oncology.

[74]  M. Morino,et al.  D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial. , 2021, European journal of cancer.

[75]  Brenessa Lindeman,et al.  Prophylactic Central Neck Dissection in Papillary Thyroid Carcinoma: All Risks, No Reward. , 2021, The Journal of surgical research.

[76]  Yutaka Suzuki,et al.  Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer , 2021, JCI insight.

[77]  S. Fanti,et al.  Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer , 2021, The Journal of Nuclear Medicine.

[78]  K. Rock,et al.  Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation , 2021, Frontiers in Immunology.

[79]  Yurong Zhou,et al.  Case Report: Intercostal Lymph Node Metastasis: A Case Report and Review of the Literature , 2021, Frontiers in Oncology.

[80]  Joe Y. Chang,et al.  NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[81]  T. Padera,et al.  Progression of Metastasis through Lymphatic System , 2021, Cells.

[82]  Tianxin Lin,et al.  Lymphatic metastasis of bladder cancer: Molecular mechanisms, diagnosis and targeted therapy. , 2021, Cancer letters.

[83]  G. Whitman,et al.  Breast Cancer Staging: Updates in the AJCC Cancer Staging Manual 8th Edition and Current Challenges for Radiologists, From the AJR Special Series on Cancer Staging. , 2021, AJR. American journal of roentgenology.

[84]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[85]  Jian Huang,et al.  circEHBP1 promotes lymphangiogenesis and lymphatic metastasis of bladder cancer via miR-130a-3p/TGFβR1/VEGF-D signaling , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[86]  M. Morse,et al.  Vaccine Therapies for Cancer: Then and Now , 2021, Targeted Oncology.

[87]  A. Riddell,et al.  CT diagnosis of ilioinguinal lymph node metastases in melanoma using radiological characteristics beyond size and asymmetry , 2021, BJS open.

[88]  T. H. van der Kwast,et al.  Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression , 2021, Nature Cell Biology.

[89]  F. Wärnberg,et al.  Remodeling of the Lymph Node High Endothelial Venules Reflects Tumor Invasiveness in Breast Cancer and is Associated with Dysregulation of Perivascular Stromal Cells , 2021, Cancers.

[90]  Fazhan Wang,et al.  [Progress in targeting therapy of cancer metastasis by CCL21/CCR7 axis]. , 2020, Sheng wu gong cheng xue bao = Chinese journal of biotechnology.

[91]  Lunxu Liu,et al.  Lobe-Specific Node Dissection Can Be a Suitable Alternative to Systematic Lymph Node Dissection in Highly Selective Early-Stage Non-Small-Cell Lung Cancer Patients: A Meta-Analysis , 2020, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[92]  Sharyn I. Katz,et al.  CT for detection of malignant posterior intercostal lymph nodes in patients undergoing pre-operative staging for malignant pleural mesothelioma. , 2020, Lung cancer.

[93]  Hong Yang,et al.  Using ultrasound features and radiomics analysis to predict lymph node metastasis in patients with thyroid cancer , 2020, BMC Surgery.

[94]  M. Noguchi,et al.  Axillary surgery for breast cancer: past, present, and future , 2020, Breast Cancer.

[95]  Yong-Hee Kim,et al.  Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study. , 2020, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[96]  E. van Limbergen,et al.  Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial. , 2020, The Lancet. Oncology.

[97]  Zheng Hu,et al.  Periostin+cancer‐associated fibroblasts promote lymph node metastasis by impairing the lymphatic endothelial barriers in cervical squamous cell carcinoma , 2020, Molecular oncology.

[98]  M. Intra,et al.  Axillary surgery in breast cancer: An updated historical perspective. , 2020, Seminars in oncology.

[99]  J. Guan,et al.  Interrogation of Folic Acid-Functionalized Nanomedicines: The Regulatory Roles of Plasma Proteins Reexamined. , 2020, ACS nano.

[100]  Chunhong Hu,et al.  Self-Assembled Hybrid Nanocomposites for Multimodal Imaging-Guided Photothermal Therapy of Lymph Node Metastasis. , 2020, ACS applied materials & interfaces.

[101]  F. Tan,et al.  Lobe-specific Lymph Node Dissection in Clinical Stage IA Solid-dominant Non-small-cell Lung Cancer: A Propensity Score Matching Study. , 2020, Clinical lung cancer.

[102]  Di Wu,et al.  PRMT5/Wnt4 axis promotes lymph-node metastasis and proliferation of laryngeal carcinoma , 2020, Cell Death & Disease.

[103]  E. Aly,et al.  Lateral pelvic lymph node dissection in the management of locally advanced low rectal cancer: Summary of the current evidence. , 2020, Surgical oncology.

[104]  Xiaoquan Yang,et al.  Metastatic status of sentinel lymph nodes in breast cancer determined with photoacoustic microscopy via dual-targeting nanoparticles , 2020, Light, science & applications.

[105]  A. Bergenfelz,et al.  Central lymph node dissection and permanent hypoparathyroidism after total thyroidectomy for papillary thyroid cancer: population-based study. , 2020, The British journal of surgery.

[106]  L. Boon,et al.  The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes. , 2020, Cancer cell.

[107]  R. Mukherjee,et al.  Lymph node extracapsular extension as a marker of aggressive phenotype: Classification, prognosis and associated molecular biomarkers. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[108]  Junjie Chen,et al.  Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis , 2020, Breast.

[109]  J. Weitz,et al.  Definition and severity grading of postoperative lymphatic leakage following inguinal lymph node dissection , 2020, Langenbeck's Archives of Surgery.

[110]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[111]  Zemin Zhang,et al.  The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications , 2020, Cellular & Molecular Immunology.

[112]  Sharyn I. Katz,et al.  Posterior Intercostal Lymph Nodes Double Recurrence and Death Risk in Malignant Pleural Mesothelioma. , 2020, Annals of Thoracic Surgery.

[113]  A. Vincent-Salomon,et al.  Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients , 2020, Nature Communications.

[114]  R. Osarogiagbon,et al.  Survival after mediastinal node dissection, systematic sampling or neither for early-stage non-small-cell lung cancer. , 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[115]  H. Gu,et al.  A stable USPIO capable for MR lymphography with Ultra-low effective dosage. , 2020, Nanomedicine : nanotechnology, biology, and medicine.

[116]  Stephen M. Shaw,et al.  BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial , 2020, Nature Medicine.

[117]  Jessica C. Hsu,et al.  Nanoparticle contrast agents for X-ray imaging applications. , 2020, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[118]  S. Shahrara,et al.  The pathogenic importance of CCL21 and CCR7 in rheumatoid arthritis. , 2020, Cytokine & growth factor reviews.

[119]  S. Yao,et al.  FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism , 2020, Theranostics.

[120]  Changhao Chen,et al.  circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer , 2020, Molecular Cancer.

[121]  Jeffrey J. Quinn,et al.  Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts , 2020, bioRxiv.

[122]  Ji Hoon Kang,et al.  Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for ≥ pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[123]  Pengjie Tu,et al.  Novel technique for lymphadenectomy along left recurrent laryngeal nerve during thoracoscopic esophagectomy , 2020, World journal of gastroenterology.

[124]  S. Turley,et al.  Lymph node stromal cells: cartographers of the immune system , 2020, Nature Immunology.

[125]  N. Lawrentschuk,et al.  Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study , 2020, The Lancet.

[126]  Tingting Qin,et al.  Clinical importance of VEGFC and PD‐L1 co‐expression in lung adenocarcinoma patients , 2020, Thoracic cancer.

[127]  Hailin Tang,et al.  Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer , 2020, Journal of Hematology & Oncology.

[128]  T. Fahey,et al.  The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. , 2020, Annals of surgery.

[129]  S. Jalkanen,et al.  Lymphatic endothelial cells of the lymph node , 2020, Nature Reviews Immunology.

[130]  Jingwen Liu,et al.  Development of tumour peptide vaccines: From universalization to personalization , 2020, Scandinavian journal of immunology.

[131]  Lingzhou Zhao,et al.  LyP-1-Modified Multifunctional Dendrimers for Targeted Anti-Tumor and Anti-Metastasis Therapy. , 2020, ACS applied materials & interfaces.

[132]  Japanese Gastric Cancer Association.  Japanese gastric cancer treatment guidelines 2018 (5th edition) , 2020, Gastric Cancer.

[133]  M. Abdelhamid,et al.  Evaluation of Axillary Reverse Mapping (ARM) in Clinically Axillary Node Negative Breast Cancer Patients - - Randomised controlled trial. , 2020, International journal of surgery.

[134]  J. Bishop,et al.  Detection of Lymph Node Metastases by Ultra-pH-Sensitive Polymeric Nanoparticles , 2020, Theranostics.

[135]  Bai Yang,et al.  Multiplexed NIR‐II Probes for Lymph Node‐Invaded Cancer Detection and Imaging‐Guided Surgery , 2020, Advanced materials.

[136]  Takeshi Aoki,et al.  Minimally invasive esophagectomy and radical lymph node dissection without recurrent laryngeal nerve paralysis , 2020, Surgical Endoscopy.

[137]  M. Tokeshi,et al.  The effect of size and charge of lipid nanoparticles prepared by microfluidic mixing on their lymph node transitivity and distribution. , 2020, Molecular pharmaceutics.

[138]  A. Kim,et al.  Disparities in Guideline Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer. , 2020, The Annals of thoracic surgery.

[139]  Burkhard Ludewig,et al.  Topological Structure and Robustness of the Lymph Node Conduit System. , 2020, Cell reports.

[140]  L. Kennedy,et al.  A review of cancer immunotherapy toxicity , 2020, CA: a cancer journal for clinicians.

[141]  Yili Yang,et al.  CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer , 2020, Theranostics.

[142]  A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers. , 2020, Case Medical Research.

[143]  S. Achkasov,et al.  Short‐term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial) , 2019, The British journal of surgery.

[144]  K. Hunt,et al.  The Landmark Series: Axillary Management in Breast Cancer , 2019, Annals of Surgical Oncology.

[145]  Tianxin Lin,et al.  Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. , 2019, The Journal of clinical investigation.

[146]  Mithat Gönen,et al.  Molecular phenotyping and image-guided surgical treatment of melanoma using spectrally distinct ultrasmall core-shell silica nanoparticles , 2019, Science Advances.

[147]  M. Papotti,et al.  Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[148]  P. Timpson,et al.  Fluids and their mechanics in tumour transit: shaping metastasis , 2019, Nature Reviews Cancer.

[149]  Victor G. Martinez,et al.  Fibroblastic Reticular Cells Control Conduit Matrix Deposition during Lymph Node Expansion , 2019, Cell reports.

[150]  A. Ohtsuka,et al.  Lower-Limb Lymphatic Drainage Pathways and Lymph Nodes: A CT Lymphangiography Cadaver Study. , 2019, Radiology.

[151]  Tanya W. Moseley,et al.  Imaging-Based Approach to Axillary Lymph Node Staging and Sentinel Lymph Node Biopsy in Patients With Breast Cancer. , 2019, AJR. American journal of roentgenology.

[152]  Jing-Wei Lin,et al.  Current state of esophageal cancer surgery in China: a national database analysis , 2019, BMC Cancer.

[153]  Yong-Hee Kim,et al.  Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer. , 2019, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[154]  G. Floris,et al.  Podoplanin-Expressing Macrophages Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer. , 2019, Cell metabolism.

[155]  N. Devoogdt,et al.  Theranostics in immuno-oncology using nanobody derivatives , 2019, Theranostics.

[156]  Qinghua Zhou,et al.  Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How? , 2019, Annals of Surgical Oncology.

[157]  K. Pinker,et al.  Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools , 2019, The oncologist.

[158]  P. Low,et al.  A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer. , 2019, Gynecologic oncology.

[159]  M. Paolillo,et al.  Extracellular Matrix Alterations in Metastatic Processes , 2019, International journal of molecular sciences.

[160]  Xiang-yi Ma,et al.  TMTP1-modified Indocyanine Green-loaded Polymeric Micelles for Targeted Imaging of Cervical Cancer and Metastasis Sentinel Lymph Node in vivo , 2019, Theranostics.

[161]  M. Faries,et al.  The Landmark Series: MSLT-1, MSLT-2 and DeCOG (Management of Lymph Nodes) , 2019, Annals of Surgical Oncology.

[162]  Sarika Wairkar,et al.  Recent developments and clinical applications of surgical glues: An overview. , 2019, International journal of biological macromolecules.

[163]  H. Katayama,et al.  Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002) , 2019, Gastric Cancer.

[164]  A. Diamantis,et al.  Current role of lymphadenectomy in gastric cancer surgery. , 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[165]  J. Cheong,et al.  VEGF-C induced by TGF- β1 signaling in gastric cancer enhances tumor-induced lymphangiogenesis , 2019, BMC Cancer.

[166]  Xue-wen Zhang,et al.  Impact of Different Types of Lymphadenectomy Combined With Different Extents of Tumor Resection on Survival Outcomes of Stage I Non-small-cell Lung Cancer: A Large-Cohort Real-World Study , 2019, Front. Oncol..

[167]  G. Gakis.  Re: Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. , 2019, European urology.

[168]  B. Dong,et al.  The NQO1/PKLR axis promotes lymph node metastasis and breast cancer progression by modulating glycolytic reprogramming. , 2019, Cancer letters.

[169]  Jaesook Park,et al.  Tumor microenvironment-responsive fluorogenic nanoprobe for ratiometric dual-channel imaging of lymph node metastasis. , 2019, Colloids and surfaces. B, Biointerfaces.

[170]  Bo Wei,et al.  Ultrasmall superparamagnetic nanoparticles targeting E-selectin: synthesis and effects in mice in vitro and in vivo , 2019, International journal of nanomedicine.

[171]  M. Nagino,et al.  The impact of cervical lymph node dissection on acid and duodenogastroesophageal reflux after intrathoracic esophagogastrostomy following transthoracic esophagectomy , 2019, Surgery Today.

[172]  C. Caldas,et al.  T cell Bispecific Antibodies in Node-Positive Breast Cancer: Novel Therapeutic Avenue for MHC class I Loss Variants. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[173]  G. Choi,et al.  Clinical Implications of Lymph Node Metastasis in Colorectal Cancer: Current Status and Future Perspectives , 2019, Annals of coloproctology.

[174]  Susanna I. Lee,et al.  2018 FIGO Staging System for Uterine Cervical Cancer: Enter Cross-sectional Imaging. , 2019, Radiology.

[175]  E. Rutgers,et al.  Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node , 2019, Journal of Immunotherapy for Cancer.

[176]  I. Hong,et al.  Quantitative computed tomography texture analysis: can it improve diagnostic accuracy to differentiate malignant lymph nodes? , 2019, Cancer Imaging.

[177]  Sanjay Singh,et al.  Magnetic Nanoparticles: Current Trends and Future Aspects in Diagnostics and Nanomedicine. , 2019, Current drug metabolism.

[178]  G. Sammarco,et al.  Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer , 2019, International journal of molecular sciences.

[179]  Anna Falk Delgado,et al.  Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma , 2019, Current Oncology Reports.

[180]  Mingyuan Gao,et al.  Rational Design and Synthesis of a Metalloproteinase-Activatable Probe for Dual-Modality Imaging of Metastatic Lymph Nodes in Vivo. , 2019, The Journal of organic chemistry.

[181]  S. Shariat,et al.  Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization , 2019, World Journal of Urology.

[182]  J. Shah,et al.  Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and Implications , 2019, Current Oncology Reports.

[183]  Y. Tomita,et al.  Precision surgical approach with lymph-node dissection in early gastric cancer , 2019, World journal of gastroenterology.

[184]  Scott N. Mueller,et al.  The Interplay Between Lymphatic Vessels and Chemokines , 2019, Front. Immunol..

[185]  J. Berek,et al.  Revised FIGO staging for carcinoma of the cervix uteri , 2019, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[186]  G. Kwon,et al.  Lymphatic changes in cancer and drug delivery to the lymphatics in solid tumors. , 2019, Advanced drug delivery reviews.

[187]  R. Fiorotto,et al.  Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma. , 2019, Journal of hepatology.

[188]  Shravan Morla.  Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation , 2019, International journal of molecular sciences.

[189]  P. Albers,et al.  Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. , 2019, European urology.

[190]  O. Nieweg,et al.  Clinical importance and surgical management of sentinel lymph nodes in the popliteal fossa of melanoma patients. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[191]  Xiaoquan Yang,et al.  Long-Distance Tracing of the Lymphatic System with a Computed Tomography/Fluorescence Dual-Modality Nanoprobe for Surveying Tumor Lymphatic Metastasis. , 2019, Bioconjugate chemistry.

[192]  J. Kochenderfer,et al.  Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management. , 2019, Blood reviews.

[193]  J. Sheinfeld,et al.  Current controversies on the role of retroperitoneal lymphadenectomy for testicular cancer. , 2019, Urologic oncology.

[194]  A. Hakimi,et al.  Role of lymph node dissection in renal cell cancer. , 2019, Urologic oncology.

[195]  Jae-Weon Kim,et al.  A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms , 2019, The New England journal of medicine.

[196]  Wen-He Huang,et al.  Over-expression of both VEGF-C and Twist predicts poor prognosis in human breast cancer , 2019, Clinical and Translational Oncology.

[197]  R. Hollingsworth,et al.  Turning the corner on therapeutic cancer vaccines , 2019, npj Vaccines.

[198]  G. Koh,et al.  Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation , 2019, Science.

[199]  Ling Huang,et al.  Comparison of D2 and D2 plus radical surgery for advanced distal gastric cancer: a randomized controlled study , 2019, World Journal of Surgical Oncology.

[200]  I. Erdogdu.  MHC Class 1 and PDL-1 Status of Primary Tumor and Lymph Node Metastatic Tumor Tissue in Gastric Cancers , 2019, Gastroenterology research and practice.

[201]  T. Werner,et al.  The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer , 2019, Molecular Imaging and Biology.

[202]  K. Farsad,et al.  Applications of nanoparticles in biomedical imaging. , 2019, Nanoscale.

[203]  Xuetao Cao,et al.  Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG , 2019, Nature Medicine.

[204]  Seyed Mohammadali Dadfar,et al.  Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications , 2019, Advanced drug delivery reviews.

[205]  M. Kneilling,et al.  Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy. , 2018, JCI insight.

[206]  Javier A. Montoya-Zegarra,et al.  Mechanisms of Tumor-Induced Lymphovascular Niche Formation in Draining Lymph Nodes , 2018, Cell reports.

[207]  M. Dhodapkar,et al.  Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance , 2018, Journal of Immunotherapy for Cancer.

[208]  Mingyuan Gao,et al.  Detection of lymph node metastasis with near-infrared upconversion luminescent nanoprobes. , 2018, Nanoscale.

[209]  Douglas B. Johnson,et al.  Biological Consequences of MHC-II Expression by Tumor Cells in Cancer , 2018, Clinical Cancer Research.

[210]  C. Reis e Sousa,et al.  The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity , 2018, Trends in cancer.

[211]  J. Munson,et al.  Convective forces increase CXCR4-dependent glioblastoma cell invasion in GL261 murine model , 2018, Scientific Reports.

[212]  M. C. Bonferoni,et al.  Nanoparticles in detection and treatment of lymph node metastases: an update from the point of view of administration routes , 2018, Expert opinion on drug delivery.

[213]  R. Gelber,et al.  Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. , 2018, The Lancet. Oncology.

[214]  Hsinyu Lee,et al.  LPA1/3 signaling mediates tumor lymphangiogenesis through promoting CRT expression in prostate cancer. , 2018, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[215]  Carola Berking,et al.  Melanoma , 2018, The Lancet.

[216]  N. Lawrentschuk,et al.  Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer , 2018, Nature Reviews Urology.

[217]  Tara A. Lee,et al.  Interstitial flow promotes macrophage polarization toward an M2 phenotype , 2018, Molecular biology of the cell.

[218]  Jian-Hua Fu,et al.  Incidence and Distribution of Lobe-Specific Mediastinal Lymph Node Metastasis in Non-small Cell Lung Cancer: Data from 4511 Resected Cases , 2018, Annals of Surgical Oncology.

[219]  N. Xu,et al.  Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis , 2018, International journal of biological sciences.

[220]  H. Izutani,et al.  Hoarseness after radical surgery with systematic lymph node dissection for primary lung cancer , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[221]  Wan-bin He,et al.  Lymph node ratio is an independent prognostic factor for rectal cancer after neoadjuvant therapy: A meta‐analysis , 2018, Journal of evidence-based medicine.

[222]  T. Demmy,et al.  Effect of the number of lymph nodes examined on the survival of patients with stage I non–small cell lung cancer who undergo sublobar resection , 2018, The Journal of thoracic and cardiovascular surgery.

[223]  S. Wiseman,et al.  American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, Prevention, and Management in Adults. , 2018, Thyroid : official journal of the American Thyroid Association.

[224]  P. Nandi,et al.  Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer , 2018, Cancer and Metastasis Reviews.

[225]  Michael L. Wang,et al.  T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[226]  Douglas B. Evans,et al.  Prophylactic Central Compartment Neck Dissection in Papillary Thyroid Cancer and Effect on Locoregional Recurrence , 2018, Annals of Surgical Oncology.

[227]  Song Liu,et al.  Tumor-targeting CuS nanoparticles for multimodal imaging and guided photothermal therapy of lymph node metastasis. , 2018, Acta biomaterialia.

[228]  Z. Bago-Horvath,et al.  Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice , 2018, Science.

[229]  Eelco F. J. Meijer,et al.  Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice , 2018, Science.

[230]  M. C. Bonferoni,et al.  Lymph node metastases: importance of detection and treatment strategies , 2018, Expert opinion on drug delivery.

[231]  E. Loh,et al.  Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma with Clinically Uninvolved Central Neck Lymph Nodes: A Systematic Review and Meta-analysis , 2018, World Journal of Surgery.

[232]  T. Padera,et al.  Growth and Immune Evasion of Lymph Node Metastasis , 2018, Front. Oncol..

[233]  M. Okada,et al.  A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413). , 2018, Japanese journal of clinical oncology.

[234]  Roy S. Herbst,et al.  The biology and management of non-small cell lung cancer , 2018, Nature.

[235]  Xu Chen,et al.  Long noncoding RNA BLACAT2 promotes bladder cancer–associated lymphangiogenesis and lymphatic metastasis , 2018, The Journal of clinical investigation.

[236]  J. Kochenderfer,et al.  Chimeric antigen receptor T-cell therapies for multiple myeloma. , 2017, Blood.

[237]  Yanchun Liang,et al.  LNMICC Promotes Nodal Metastasis of Cervical Cancer by Reprogramming Fatty Acid Metabolism. , 2017, Cancer research.

[238]  Y. Fujisawa,et al.  Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response. , 2017, Journal of dermatological science.

[239]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[240]  John N Aarsvold,et al.  Sentinel Lymph Node Biopsy Procedures. , 2017, Seminars in nuclear medicine.

[241]  Chiun-Sheng Huang,et al.  TGF‐β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up‐regulation of IL‐17RB , 2017, EMBO molecular medicine.

[242]  S. Rosenberg,et al.  Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[243]  S. Mclaughlin,et al.  Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options , 2017, Annals of Surgical Oncology.

[244]  H. Hofmann,et al.  Folic acid on iron oxide nanoparticles: platform with high potential for simultaneous targeting, MRI detection and hyperthermia treatment of lymph node metastases of prostate cancer. , 2017, Dalton transactions.

[245]  R. Savai,et al.  S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β , 2017, The Journal of experimental medicine.

[246]  E. D. de Vries,et al.  Evolution in sentinel lymph node biopsy in breast cancer. , 2017, Critical reviews in oncology/hematology.

[247]  H. Lee,et al.  Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling , 2017, PloS one.

[248]  T. Tu,et al.  CD146 is required for VEGF-C-induced lymphatic sprouting during lymphangiogenesis , 2017, Scientific Reports.

[249]  J. Byrd,et al.  Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[250]  E. Oki,et al.  "Energy-less technique" with mini-clips for recurrent laryngeal nerve lymph node dissection in prone thoracoscopic esophagectomy for esophageal cancer. , 2017, American Journal of Surgery.

[251]  Johannes G. Reiter,et al.  Origins of lymphatic and distant metastases in human colorectal cancer , 2017, Science.

[252]  Muhammad S. Khan,et al.  Landmarks in the treatment of muscle-invasive bladder cancer , 2017, Nature Reviews Urology.

[253]  C. Mazouni,et al.  Use of Low‐Thrombin Fibrin Sealant Glue After Axillary Lymphadenectomy for Breast Cancer to Reduce Hospital Length and Seroma , 2017, Clinical breast cancer.

[254]  D. Kraus,et al.  Indications and extent of central neck dissection for papillary thyroid cancer: An American Head and Neck Society Consensus Statement , 2017, Head & neck.

[255]  A. Gesierich,et al.  Completion Dissection or Observation for Sentinel‐Node Metastasis in Melanoma , 2017, The New England journal of medicine.

[256]  Nancy D Perrier,et al.  Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? , 2017, Thyroid : official journal of the American Thyroid Association.

[257]  B. Fabris,et al.  Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center. , 2017, International journal of surgery.

[258]  V. Master,et al.  Contemporary management of patients with penile cancer and lymph node metastasis , 2017, Nature Reviews Urology.

[259]  J. Friedberg,et al.  Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[260]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[261]  W. Ju,et al.  Prevention of lymphocele by using gelatin-thrombin matrix as a tissue sealant after pelvic lymphadenectomy in patients with gynecologic cancers: a prospective randomized controlled study , 2017, Journal of gynecologic oncology.

[262]  R. van Hillegersberg,et al.  A High Lymph Node Yield is Associated with Prolonged Survival in Elderly Patients Undergoing Curative Gastrectomy for Cancer: A Dutch Population-Based Cohort Study , 2017, Annals of Surgical Oncology.

[263]  A. Biondi,et al.  N staging: the role of the pathologist. , 2017, Translational gastroenterology and hepatology.

[264]  A. Noël,et al.  Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model , 2017, Laboratory Investigation.

[265]  N. Bartlett,et al.  Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[266]  Xiaoyuan Chen,et al.  Mapping Sentinel Lymph Node Metastasis by Dual-probe Optical Imaging , 2017, Theranostics.

[267]  Camille Stephan-Otto Attolini,et al.  Targeting metastasis-initiating cells through the fatty acid receptor CD36 , 2016, Nature.

[268]  Syed Abbas Ali,et al.  T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma. , 2016, Blood.

[269]  S. Heimfeld,et al.  Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells , 2016, Science Translational Medicine.

[270]  R. Wong,et al.  Comprehensive management of recurrent thyroid cancer: An American Head and Neck Society consensus statement , 2016, Head & neck.

[271]  Eelco F. J. Meijer,et al.  The Lymphatic System in Disease Processes and Cancer Progression. , 2016, Annual review of biomedical engineering.

[272]  S. O’Day,et al.  Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma. , 2016, Journal of the American College of Surgeons.

[273]  Jay W. Shin,et al.  DeepCAGE transcriptomics identify HOXD10 as a transcription factor regulating lymphatic endothelial responses to VEGF-C , 2016, Journal of Cell Science.

[274]  Feng Jiang,et al.  A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune Checkpoints , 2016, International journal of molecular sciences.

[275]  Japanese Gastric Cancer Association.  Japanese gastric cancer treatment guidelines 2014 (ver. 4) , 2016, Gastric Cancer.

[276]  B. Hall,et al.  Tumor Induced Stromal Reprogramming Drives Lymph Node Transformation , 2016, Nature Immunology.

[277]  C. Berking,et al.  Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. , 2016, The Lancet. Oncology.

[278]  Daniel Li,et al.  CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. , 2016, The Journal of clinical investigation.

[279]  K. Kumamoto,et al.  Clinicopathological significance of lymphangiogenesis detected by immunohistochemistry using D2-40 monoclonal antibody in breast cancer. , 2016, Fukushima journal of medical science.

[280]  W. Kastenmüller,et al.  Lymph node – an organ for T‐cell activation and pathogen defense , 2016, Immunological reviews.

[281]  F. She,et al.  TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway , 2016, BMC Cancer.

[282]  P. Scardino,et al.  Detection of Lymph Node Metastases with SERRS Nanoparticles , 2016, Molecular Imaging and Biology.

[283]  J. Zhuang,et al.  IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer. , 2016, Oncology reports.

[284]  K. Hirakawa,et al.  Tumor-Associated Macrophages Extend Along Lymphatic Flow in the Pre-metastatic Lymph Nodes of Human Gastric Cancer , 2016, Annals of Surgical Oncology.

[285]  N. Nishiyama,et al.  cRGD-installed polymeric micelles loading platinum anticancer drugs enable cooperative treatment against lymph node metastasis. , 2015, Journal of Controlled Release.

[286]  Hisao Asamura,et al.  The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[287]  J. Coll,et al.  Role of near-infrared fluorescence imaging in the resection of metastatic lymph nodes in an optimized orthotopic animal model of HNSCC. , 2015, European annals of otorhinolaryngology, head and neck diseases.

[288]  Mingming Wu,et al.  Interstitial flows promote amoeboid over mesenchymal motility of breast cancer cells revealed by a three dimensional microfluidic model. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[289]  A. Ruddell,et al.  Tumor-induced lymph node alterations detected by MRI lymphography using gadolinium nanoparticles , 2015, Scientific Reports.

[290]  Christopher J. H. Porter,et al.  From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity , 2015, Nature Reviews Drug Discovery.

[291]  David L. Porter,et al.  Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia , 2015, Science Translational Medicine.

[292]  D. Berry,et al.  Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance). , 2015, Annals of surgery.

[293]  Yiping Yang,et al.  Cancer immunotherapy: harnessing the immune system to battle cancer. , 2015, The Journal of clinical investigation.

[294]  X. Guan,et al.  Cancer metastases: challenges and opportunities , 2015, Acta pharmaceutica Sinica. B.

[295]  K. Jung,et al.  The Benefits and Risks of Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma: Prospective Cohort Study , 2015, International journal of endocrinology.

[296]  Xiang-yi Ma,et al.  Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT. , 2015, Nuclear medicine and biology.

[297]  Sadik H. Kassim,et al.  Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[298]  E. Tutunea-Fatan,et al.  The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis , 2015, Molecular Cancer.

[299]  J. Jonkers,et al.  IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis , 2015, Nature.

[300]  S. Steinberg,et al.  T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial , 2015, The Lancet.

[301]  Mingyuan Gao,et al.  Ultrasensitive in vivo detection of primary gastric tumor and lymphatic metastasis using upconversion nanoparticles. , 2015, ACS nano.

[302]  Christopher J. H. Porter,et al.  Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[303]  S. Narumiya,et al.  Prostanoid induces premetastatic niche in regional lymph nodes. , 2014, The Journal of clinical investigation.

[304]  J. Bogaerts,et al.  Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. , 2014, The Lancet. Oncology.

[305]  Pamela A Shaw,et al.  Chimeric antigen receptor T cells for sustained remissions in leukemia. , 2014, The New England journal of medicine.

[306]  R. Gutzmer,et al.  Is there a therapeutic benefit of complete lymph node dissection in melanoma patients with low tumor burden in the sentinel node? , 2014, Melanoma research.

[307]  L. Natarajan,et al.  The psychosocial impact of lymphedema‐related distress among breast cancer survivors in the WHEL Study , 2014, Psycho-oncology.

[308]  C. Kane,et al.  How to Minimize Lymphoceles and Treat Clinically Symptomatic Lymphoceles After Radical Prostatectomy , 2014, Current Urology Reports.

[309]  Manuchehr Shirmohamadi.  A Patient’s Perspective , 2014 .

[310]  J. Izbicki,et al.  Molecular Changes in Pre-Metastatic Lymph Nodes of Esophageal Cancer Patients , 2014, PloS one.

[311]  Kwangmeyung Kim,et al.  Accurate sequential detection of primary tumor and metastatic lymphatics using a temperature-induced phase transition nanoparticulate system , 2014, International journal of nanomedicine.

[312]  Q. Guan,et al.  Systematic review and meta‐analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer , 2014, The British journal of surgery.

[313]  Yu-cheng Tseng,et al.  Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases. , 2014, Biomaterials.

[314]  A. Nashimoto,et al.  Neoadjuvant chemotherapy with S‐1 and cisplatin followed by D2 gastrectomy with para‐aortic lymph node dissection for gastric cancer with extensive lymph node metastasis , 2014, The British journal of surgery.

[315]  F. Massera,et al.  Metastasis to subsegmental and segmental lymph nodes in patients resected for non-small cell lung cancer: prognostic impact. , 2014, The Annals of thoracic surgery.

[316]  Qing He,et al.  Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia , 2014, Science Translational Medicine.

[317]  O. Farokhzad,et al.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced Drug Delivery Reviews.

[318]  E. Kandil,et al.  The impact of surgical volume on patient outcomes following thyroid surgery. , 2013, Surgery.

[319]  Maria Triantafyllou,et al.  Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. , 2013, European urology.

[320]  P. Ye,et al.  Insulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer. , 2013, World journal of gastroenterology.

[321]  Sathish Kumar Mungamuri,et al.  Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses , 2013, The Journal of experimental medicine.

[322]  R. Mansel,et al.  Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcome. , 2013, European journal of cancer.

[323]  S. Vandenberg,et al.  PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes , 2013, Proceedings of the National Academy of Sciences.

[324]  Geoffrey E. Wile,et al.  Penile cancer: Clinical Practice Guidelines in Oncology. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

[325]  J. Crook,et al.  Current concepts in penile cancer. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

[326]  T. Sawada,et al.  Association of MHC class I expression and lymph node metastasis of gastric carcinoma. , 2013, Hepato-gastroenterology.

[327]  A. Chang,et al.  Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.

[328]  M. Matoba,et al.  Advantages of Diffusion-Weighted Imaging Over Positron Emission Tomography-Computed Tomography in Assessment of Hilar and Mediastinal Lymph Node in Lung Cancer , 2013, Annals of Surgical Oncology.

[329]  A. Luini,et al.  Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. , 2013, The Lancet. Oncology.

[330]  A. Sawka,et al.  Controversies in primary treatment of low-risk papillary thyroid cancer , 2013, The Lancet.

[331]  Qing He,et al.  CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia , 2013, Science Translational Medicine.

[332]  C. Kane,et al.  Outcomes and complications of pelvic lymph node dissection during robotic-assisted radical prostatectomy , 2013, World Journal of Urology.

[333]  Li Tang,et al.  Aptamer-functionalized, ultra-small, monodisperse silica nanoconjugates for targeted dual-modal imaging of lymph nodes with metastatic tumors. , 2012, Angewandte Chemie.

[334]  S. Mandel,et al.  The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. , 2012, Thyroid : official journal of the American Thyroid Association.

[335]  Juan Zhang,et al.  Mitochondrial dynamics regulates migration and invasion of breast cancer cells , 2012, Oncogene.

[336]  T. Henzler,et al.  Predicting malignancy in mediastinal lymph nodes by endobronchial ultrasound: A new ultrasound scoring system , 2012, Respirology.

[337]  A. Testori,et al.  Prognosis in patients with sentinel node‐positive melanoma without immediate completion lymph node dissection , 2012, The British journal of surgery.

[338]  E. Rofstad,et al.  Interstitial fluid pressure and associated lymph node metastasis revealed in tumors by dynamic contrast-enhanced MRI. , 2012, Cancer research.

[339]  U. Veronesi,et al.  Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND). , 2012, Breast.

[340]  H. Hurwitz,et al.  Anti-VEGF therapies in the clinic. , 2012, Cold Spring Harbor perspectives in medicine.

[341]  Reinhold Förster,et al.  HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes , 2012, Nature Reviews Immunology.

[342]  H. Ji,et al.  Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis , 2012, Proceedings of the National Academy of Sciences.

[343]  Nicolas Bertrand,et al.  The journey of a drug-carrier in the body: an anatomo-physiological perspective. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[344]  Lixin Lang,et al.  Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes. , 2012, Biomaterials.

[345]  R. Figlin,et al.  S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. , 2012, Cancer cell.

[346]  I. Do,et al.  Lymphatic Vessels and High Endothelial Venules are Increased in the Sentinel Lymph Nodes of Patients with Oral Squamous Cell Carcinoma Before the Arrival of Tumor Cells , 2012, Annals of Surgical Oncology.

[347]  Theodosis S. Papavramidis,et al.  Secretory capacity of the parathyroid glands after total thyroidectomy in normocalcemic subjects. , 2012, The Journal of clinical endocrinology and metabolism.

[348]  S. Rosenberg,et al.  B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. , 2012, Blood.

[349]  M. Swartz,et al.  Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity , 2012, Nature Reviews Cancer.

[350]  A. Mansfield,et al.  Regional lymphatic immunity in melanoma , 2012, Melanoma research.

[351]  Sunkuk Kwon,et al.  Imaging prostate cancer lymph node metastases with a multimodality contrast agent , 2012, The Prostate.

[352]  Eugene Y. Kim,et al.  Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. , 2012, Cancer research.

[353]  M. Matsumoto,et al.  A role for bone morphogenetic protein-4 in lymph node vascular remodeling and primary tumor growth. , 2011, Cancer Research.

[354]  N. Shukla,et al.  Chylous fistula after axillary lymph node dissection: incidence, management, and possible cause. , 2011, Clinical breast cancer.

[355]  A. Bagg,et al.  Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. , 2011, The New England journal of medicine.

[356]  J. Clarke,et al.  What is a systematic review? , 2011, Evidence Based Nursing.

[357]  S. Wickline,et al.  Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. , 2011, Cancer research.

[358]  Simone Gritsch.  next generation , 2011 .

[359]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[360]  M. Taketo,et al.  Significance and mechanism of lymph node metastasis in cancer progression. , 2011, Cancer research.

[361]  C. Stief,et al.  Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node–Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy , 2011, Annals of Surgical Oncology.

[362]  C. Gialeli,et al.  Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting , 2011, The FEBS journal.

[363]  Jiankun Liu,et al.  Role of interleukin‐17 in lymphangiogenesis in non‐small‐cell lung cancer: Enhanced production of vascular endothelial growth factor C in non‐small‐cell lung carcinoma cells , 2010, Cancer Science.

[364]  T. Julian,et al.  Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. , 2010, The Lancet. Oncology.

[365]  R. Price,et al.  Detection of Cancer Metastases with a Dual-labeled Near-Infrared/Positron Emission Tomography Imaging Agent. , 2010, Translational oncology.

[366]  J. Alexander,et al.  Gastrointestinal lymphatics in health and disease. , 2010, Pathophysiology : the official journal of the International Society for Pathophysiology.

[367]  G. Pentheroudakis,et al.  Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[368]  H. Putter,et al.  Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. , 2010, The Lancet. Oncology.

[369]  P. Foubert,et al.  Integrin α4β1 Signaling Is Required for Lymphangiogenesis and Tumor Metastasis , 2010 .

[370]  M. Loda,et al.  Fatty acid synthase as a potential therapeutic target in cancer. , 2010, Future oncology.

[371]  S. Narumiya,et al.  Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[372]  G. Sainte-Marie,et al.  The Lymph Node Revisited: Development, Morphology, Functioning, and Role in Triggering Primary Immune Responses , 2010, Anatomical record.

[373]  M. Ross,et al.  Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy is Accurate and Reduces the Need for Axillary Dissection in Breast Cancer Patients , 2009, Annals of surgery.

[374]  H. Imamura,et al.  Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer , 2009, The British journal of surgery.

[375]  S. Nathanson,et al.  The Role of Lymph Node Metastasis in the Systemic Dissemination of Breast Cancer , 2009, Annals of Surgical Oncology.

[376]  D. Steward,et al.  The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. , 2009, Thyroid : official journal of the American Thyroid Association.

[377]  Hisao Asamura,et al.  The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[378]  J. Monson,et al.  Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial , 2009, The Lancet.

[379]  E. Wang,et al.  Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer. , 2009, European journal of cancer.

[380]  Daniel G. Anderson,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[381]  Robert Langer,et al.  Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. , 2008, ACS nano.

[382]  R. Cerfolio,et al.  Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer. , 2008, The Annals of thoracic surgery.

[383]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[384]  A. Nashimoto,et al.  D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. , 2008, The New England journal of medicine.

[385]  J. Olson,et al.  Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[386]  Milan Makale,et al.  Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis , 2008, Proceedings of the National Academy of Sciences.

[387]  Lieping Chen,et al.  Inhibitory B7-family molecules in the tumour microenvironment , 2008, Nature Reviews Immunology.

[388]  J. Califano,et al.  Consensus statement on the classification and terminology of neck dissection. , 2008, Archives of otolaryngology--head & neck surgery.

[389]  S. Fosså,et al.  A MULTICENTRE, RANDOMISED, PHASE 3 TRIAL OF A NOVEL, AUTOLOGOUS, THERAPEUTIC VACCINE (VITESPEN) VS. OBSERVATION AS ADJUVANT THERAPY IN PATIENTS AT HIGH RISK OF RECURRENCE AFTER NEPHRECTOMY FOR RENAL CELL CARCINOMA , 2008 .

[390]  F. Schmidt.  Meta-Analysis , 2008 .

[391]  Elisabetta Dejana,et al.  Functionally specialized junctions between endothelial cells of lymphatic vessels , 2007, The Journal of experimental medicine.

[392]  Melody A Swartz,et al.  Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. , 2007, Cancer cell.

[393]  Ricky T. Tong,et al.  Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. , 2007, Cancer research.

[394]  B. Berghuis,et al.  Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. , 2006, Cancer research.

[395]  L. Lisabeth,et al.  Stroke Among Patients With Dizziness, Vertigo, and Imbalance in the Emergency Department: A Population-Based Study , 2006, Stroke.

[396]  Jen-Hao Chen,et al.  Nodal dissection for patients with gastric cancer: a randomised controlled trial. , 2006, The Lancet. Oncology.

[397]  K. Arihiro,et al.  Maturation of dendritic cells and T‐cell responses in sentinel lymph nodes from patients with breast carcinoma , 2006, Cancer.

[398]  Jay W. Shin,et al.  Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. , 2005, Molecular biology of the cell.

[399]  Susan Holmes,et al.  Profile of Immune Cells in Axillary Lymph Nodes Predicts Disease-Free Survival in Breast Cancer , 2005, PLoS medicine.

[400]  S. Hirakawa,et al.  Hepatocyte growth factor promotes lymphatic vessel formation and function , 2005, The EMBO journal.

[401]  G. Watkins,et al.  Interleukin 7 upregulates vascular endothelial growth factor D in breast cancer cells and induces lymphangiogenesis in vivo , 2005, The British journal of surgery.

[402]  C. Porter,et al.  Subcutaneous drug delivery and the role of the lymphatics. , 2005, Drug discovery today. Technologies.

[403]  J E Kipp,et al.  The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. , 2004, International journal of pharmaceutics.

[404]  Toshio Ohhashi,et al.  PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. , 2004, Cancer cell.

[405]  K. Hunt,et al.  Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer , 2004, Breast Cancer Research.

[406]  Y. Ohno,et al.  Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. , 2004, Radiology.

[407]  D. Wickerham,et al.  The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[408]  H. Nagawa,et al.  Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. , 2002, Surgery.

[409]  Erkki Ruoslahti,et al.  A tumor-homing peptide with a targeting specificity related to lymphatic vessels , 2002, Nature Medicine.

[410]  P. Levine,et al.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. , 2002, Archives of otolaryngology--head & neck surgery.

[411]  Rieken,et al.  [Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer]. , 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[412]  C. V. D. van de Velde,et al.  Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[413]  H. Wiley,et al.  Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. , 2001, Journal of the National Cancer Institute.

[414]  E C Nice,et al.  Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF‐C/D receptor VEGFR‐3 , 2001, The EMBO journal.

[415]  Adriana,et al.  Molecular Mechanisms , 1999 .

[416]  P. Fayers,et al.  Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial , 1999, British Journal of Cancer.

[417]  Benjamin Dan Wandelt,et al.  Precision preparation of strings of trapped neutral atoms , 2006, physics/0607294.

[418]  K. Zedeler,et al.  Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy , 1997 .

[419]  N. Le,et al.  Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. , 1997, The New England journal of medicine.

[420]  D. Wickerham,et al.  Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[421]  L Påhlman,et al.  Improved survival with preoperative radiotherapy in resectable rectal cancer. , 1997, The New England journal of medicine.

[422]  A. Lichtenstein,et al.  Depressed natural killer cell activity in cervical lymph nodes containing focal metastatic squamous cell carcinoma. , 1988, Archives of otolaryngology--head & neck surgery.

[423]  T. Lehnert,et al.  Lymph and blood capillaries of the human gastric mucosa. A morphologic basis for metastasis in early gastric carcinoma. , 1985, Gastroenterology.

[424]  Jun Ren,et al.  A retrospective cohort study , 2021 .

[425]  Xiansong Wang,et al.  Lanthanide-Based Metal–Organic Frameworks Solidi�ed by Gelatin-Methacryloyl Hydrogels For Improving the Accuracy of Localization and Excision of Small Pulmonary Nodules , 2021 .

[426]  M. Tawfik,et al.  Is routine dissection of central lymph node and radio-active iodine therapy, necessary for papillary thyroid carcinoma, T1-2 N0? A randomized controlled trial , 2020 .

[427]  E. Arbustini,et al.  Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[428]  D. Gyorki,et al.  Negative Sentinel Lymph Node Biopsy in Patients with Melanoma : The Patient ’ s Perspective , 2019 .

[429]  Susanna I. Lee,et al.  FIGO Staging System for Uterine Cervical Cancer : Enter Cross-sectional Imaging , 2019 .

[430]  Wei Huang,et al.  A meta-analysis of randomized trials , 2019 .

[431]  H. Woodrow,et al.  : A Review of the , 2018 .

[432]  María Blanca Fernández-Viñéa.  CURRENT STATUS AND FUTURE PERSPECTIVES , 2018 .

[433]  Y. Kakeji,et al.  Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007) , 2017, Gastric Cancer.

[434]  M. Tsuboi,et al.  Lobe‐Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non–Small Cell Lung Cancer: A Propensity Score Matching Study , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[435]  I. Apostolova,et al.  Imaging of Tumor Metabolism Using Positron Emission Tomography (PET). , 2016, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[436]  Charlotte E. S. Hoogstins,et al.  Novel Tumor-Speci fi c Agent for Intraoperative Near-Infrared Fluorescence Imaging : A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer , 2016 .

[437]  R. Ruggiero,et al.  Axillary lymphadenectomy for breast cancer and fibrin glue. , 2014, Annali italiani di chirurgia.

[438]  Sylvia H. Heywang-Koebrunner,et al.  Normal Lymph Nodes , 2014 .

[439]  A. Kiss,et al.  Personalized Surgery for Gastric Adenocarcinoma: A Meta-analysis of D1 versus D2 Lymphadenectomy , 2014, Annals of Surgical Oncology.

[440]  W. Cullen,et al.  What is a randomised controlled trial? , 2013, Irish medical journal.

[441]  A. Steiner,et al.  Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis. , 2013, The Journal of investigative dermatology.

[442]  Janis P Bellack,et al.  Then and now. , 2011, The Journal of nursing education.

[443]  Japanese Gastric Cancer Association.  Japanese classification of gastric carcinoma: 3rd English edition , 2011, Gastric Cancer.

[444]  M. Swartz,et al.  Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. , 2009, Cancer research.

[445]  P. Johnstone,et al.  Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment , 2009, CA: a cancer journal for clinicians.

[446]  阿部 宣子.  Clinicopathological significance of lymphangiogenesis detected by immunohistochemistry using D2-40 monoclonal antibody in breast cancer , 2008 .

[447]  S. Mookherji,et al.  Summary of Current Evidence , 2006 .

[448]  A. Mcnicol,et al.  The Role of the Pathologist , 2006 .

[449]  D. Holdstock.  Past, present--and future? , 2005, Medicine, conflict, and survival.

[450]  prospective cohort study , 2005 .

[451]  A. Ahuja,et al.  Sonography of neck lymph nodes. Part I: normal lymph nodes. , 2003, Clinical radiology.

[452]  Rajakrishnan Rajkumar,et al.  Grammar Engineering for CCG using Ant and XSLT ∗ , 2001 .

[453]  H. Espejo,et al.  [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.

[454]  胃癌研究会.  Japanese classification of gastric carcinoma , 1995 .

[455]  S. Taylor.  Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.

[456]  J. Takeda,et al.  Early gastric cancer associated with synchronous liver metastasis. , 1991, The Kurume medical journal.

[457]  J. Krmpotiĉ.  [Lymphatic system of the head and neck]. , 1965, Chirurgia maxillofacialis & plastica.